NeoVentures will be holding the 3rd Annual Aptamer Workshop in Paris on February 21 st. This is an opportunity to learn about all aspects of aptamers from the leading company in the field. Dr. Gregory Penner will be presenting a full description of our new free/free selection strategy FRELEX. We will discuss the mathematics of the selection process, and Next Generation Sequencing ( NGS) aptamer sequence analysis. We will present data on different binding assay methods and discuss the pros and cons of each one. We will also provide an update on NeoVentures’ and NeoNeuro’s latest developments on applications for diagnostics therapeutics and biomarker discovery.
Free Workshop. Pre-registration required by February 7th. 2017 at email@example.com/